As returns on market increase, Covance returns are expected to increase less than the market. However during bear market, the loss on holding Covance will be expected to be smaller as well.
Richard Cimino Executive VP and Group President of Clinical Devel.
Deborah Tanner Executive VP and Group President of RandD Laboratories
John Watson Chief Commercial Officer, Corporate Sr. VP and President of Strategic Partnering
Covance Price and Market Media
The median price of Covance for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 74.62 with a coefficient of variation of 2.0. The daily time series for the period is distributed with a sample standard deviation of 1.5, arithmetic mean of 75.07, and mean deviation of 1.26. The Stock received substential amount of media coverage during this period.
Covance Inc [CVD] is traded on New York Stock Exchange in USA. It is located in Princeton, NJ and employs 11,160 people. The company currently falls under 'Mid-Cap' category with total capitalization of 4.09 B. Covance Inc runs under Healthcare sector within Medical Laboratories and Research industry. This company has 55.12 M outstanding shares of which 2.1 M shares are currently shorted by investors with about 5.9 days to cover shorted positions.
Covance Inc., a drug development services company, offer various earlystage and latestage product development services primarily to the pharmaceutical, biotechnology, and medical device industries primarily in the United States and Europe. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
1.03%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
